Aurobindo Pharma Ltd. has been cleared by the Food and Drug Administration to market hydrocodone bitartrate and ibuprofen tablets 7.5 mg/200 mg (C-II), a combination opioid and nonsteroidal anti-inflammatory drug (NSAID) painkiller.
Perrigo Co. plc has received approval from the Food and Drug Administration for omeprazole and sodium bicarbonate capsules 20 mg/1100 mg, an over-the-counter medicine for heartburn.
Bayer has rolled out a TENS device under its Aleve pain relief brand, called Aleve Direct Therapy. The company said the back pain product is now available in the analgesics aisle at retailers nationwide.
The Radiant Collection, a feminine care line from Procter & Gamble Co.’s Tampax and Always brands, has signed on as a sponsor for “The Untouchable Tour” of singer Meghan Trainor. P&G said The Radiant Collection will be on-site at 26 dates throughout Trainor’s U.S. tour and online.
Next month, Prestige Brands Holdings Inc. chief financial officer David Marberger is slated to leave the company to join ConAgra Foods Inc. as executive vice president and CFO. Plans call for Marberger to take over the CFO post on Aug. 29, ConAgra said Thursday.
Shire plc has received Food and Drug Administration approval for Xiidra 5% (lifitegrast ophthalmic solution), a twice-daily eye drop solution for dry eye. Plans call for Xiidra to launch in the United States in the third quarter.
Lannett Co. has been cleared by the Food and Drug Administration to market paroxetine extended-release tablets, an antidepressant, in strengths of 12.5 mg, 25 mg and 37.5 mg. The company said its product, a generic version of Paxil CR extended-release tablets (12.5 mg, 25 mg and 37.
Blistex Inc. has purchased the TUCKS brand of over-the-counter rectal medications from Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Blistex said Monday that the deal includes the TUCKS businesses in North America as well as international trademark rights.
Galderma Laboratories L.P. has gained Food and Drug Administration approval for Differin Gel, an over-the-counter treatment for acne. Galderma said Friday that Differin Gel (adapalene gel 0.
Scott’s Liquid Gold-Inc. has acquired of the Prell, Denorex and Zincon brands of hair and scalp care products from Ultimark Products Inc. Scott’s said Thursday that it purchased the three consumer brands for approximately $9.1 million, subject to adjustment.
Mylan N.V. has launched fenofibrate tablets 40 mg and 120 mg, a cholesterol-lowering drug, in the United States. Mylan said Wednesday that its fenofibrate product is a generic version of Fenoglide tablets from Santarus.
Former Liberty Medical chairman and chief executive officer Frank Harvey has joined medication therapy management (MTM) service provider Mirixa Corp. as CEO. Mirixa, which announced the appointment Tuesday, said Harvey also will serve on the company’s board of directors.
The Council for Responsible Nutrition (CRN) has retained global independent safety science firm UL to develop and administer a dietary supplement product registry. The online product registry will include full label information for dietary supplements and be accessible via the web.
Mentholatum parent Rohto Pharmaceutical Co. has launched Rohto Ice All-in-One Cooling Eye Drops to address eight symptoms. The product’s mix of fast-acting ingredients promises fast, cooling relief for red, dry, itchy, irritated, burning, gritty, watery and stinging eyes.
Moberg Pharma AB has agreed to acquire New Skin, Fiber Choice and PediaCare from Prestige Brands Holdings Inc. for $40 million. The three brands had net sales of $24.4 million in the year ended March 31.
Kellogg Co. on Monday will debut Kellogg’s NYC, its first-ever permanent cafe, in Times Square. The cafe will feature dishes combining Kellogg’s cereals with distinctive ingredients. Kellogg’s NYC is designed to remind patrons of home and drive new curiosity around cereal.
